Compare LSAK & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSAK | AXGN |
|---|---|---|
| Founded | 1997 | N/A |
| Country | South Africa | United States |
| Employees | 3719 | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 425.5M | 1.7B |
| IPO Year | 2005 | 2013 |
| Metric | LSAK | AXGN |
|---|---|---|
| Price | $5.12 | $33.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $37.63 |
| AVG Volume (30 Days) | 80.6K | ★ 786.6K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $659,701,000.00 | $225,208,000.00 |
| Revenue This Year | $14.35 | $20.31 |
| Revenue Next Year | $8.60 | $16.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 16.92 | ★ 20.21 |
| 52 Week Low | $3.40 | $9.22 |
| 52 Week High | $5.54 | $36.00 |
| Indicator | LSAK | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 58.42 | 56.75 |
| Support Level | $4.38 | $30.42 |
| Resistance Level | $5.54 | $34.25 |
| Average True Range (ATR) | 0.21 | 1.44 |
| MACD | 0.02 | 0.26 |
| Stochastic Oscillator | 56.73 | 85.54 |
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates three reportable segments: Merchant, Consumer and Enterprise. Merchant, which focuses on both formal and informal sector merchants. Consumer, which focuses on individuals who have historically been excluded from traditional financial services and to whom it offers transactional accounts (banking), insurance, lending (short-term loans), payments solutions and various value-added services; and Enterprise, which comprises large-scale corporate and government organizations, including but not limited to banks, mobile network operators (MNOs) and municipalities, and, through Recharger, landlords utilizing Recharger's prepaid electricity metering solution.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.